FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Washington A. Eugene
2. Issuer Name and Ticker or Trading Symbol

JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

ONE JOHNSON & JOHNSON PLAZA
3. Date of Earliest Transaction (MM/DD/YYYY)

9/10/2019
(Street)

NEW BRUNSWICK, NJ 08933
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Share Units   (1) 9/10/2019    A     382.3880       (1)  (1) Common Stock  382.3880  $0.0000  20075.6183  D   

Explanation of Responses:
(1)  The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Washington A. Eugene
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933
X



Signatures
Maria A. Frucci, as attorney-in-fact for A. Eugene Washington 9/11/2019
**Signature of Reporting Person Date


Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Johnson and Johnson Charts.

Johnson & Johnson News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
Wednesday 1 May 2024 (2 days ago) • Business Wire
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
Tuesday 23 April 2024 (1 week ago) • Business Wire
Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More
Friday 19 April 2024 (2 weeks ago) • IH Market News
US Index Futures See Gains, Oil Prices Dip
Wednesday 17 April 2024 (2 weeks ago) • IH Market News
U.S. Stocks Finish Lackluster Session Narrowly Mixed
Wednesday 17 April 2024 (2 weeks ago) • IH Market News
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
Wednesday 17 April 2024 (2 weeks ago) • Business Wire
J&J’s Q1 2024 sales rise 2.3% to $21.4 billion
Tuesday 16 April 2024 (2 weeks ago) • IH Market News
Dow Looks To Snap Six-Day Losing Streak As UnitedHealth Surges
Tuesday 16 April 2024 (2 weeks ago) • IH Market News
U.S. Index Futures Signal Mixed Trading, Oil Prices Dip
Tuesday 16 April 2024 (2 weeks ago) • IH Market News
Ericsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More News
Tuesday 16 April 2024 (2 weeks ago) • IH Market News
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Tuesday 16 April 2024 (2 weeks ago) • Business Wire
Johnson & Johnson Reports Q1 2024 Results
Tuesday 16 April 2024 (2 weeks ago) • Business Wire